Heidi Cuthbert

ZachXBT has publicly challenged MemeCore to justify the valuation and token distribution of its M token, raising concerns about potential insider concentration.

Donald Trump’s public statements and social media posts have repeatedly triggered sharp price swings in Bitcoin, with moves ranging from 5% to 12% within minutes or hours.

Financial services provider HUB24 (ASX:HUB) reported net inflows for the third quarter of the 2026 financial year.

Nexalis Therapeutics (ASX:NX1) announced a clinical breakthrough with the screening of the first patient in its Phase 2 clinical trial for IRX-211.

True North Copper (ASX:TNC) to acquire Renegade Exploration’s (ASX:RNX) 22% interest in the Carpentaria JV.

The Australian Securities Exchange (ASX:ASX) launched the first phase of its long-awaited CHESS replacement on April 20.

Fletcher Building (ASX:FBU) received final regulatory approvals for the sale of its construction division to VINCI Construction.

Tyler Technologies (NYSE:TYL) announced today the completion of its acquisition of For The Record, a prominent provider of digital court-recording and transcription technology.

Pfizer (NYSE:PFE) and Astellas announced today that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a supplemental Biologics License Application (sBLA) for the perioperative use of Padcev (enfortumab vedotin-ejfv) in combination with Keytruda (pembrolizumab).

AstraZeneca (NASDAQ:AZN) today announced positive high-level results from its pivotal Phase III MIRANDA trial, evaluating tozorakimab as a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD).